Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Froehner
Fischer
Wirth

Cancer

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Cancer|September 15, 1995
Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequenceS E Baldus, M Vierbuchen, F G Hanisch, et al.
Cancer|April 1, 1979
Results of radiotherapy in control of stage I and II non-Hodgkin's lymphomaM G Chen, L R Prosnitz, A Gonzalez-Serva, et al.
Cancer|May 18, 1999
Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapyF C Dimeo, R D Stieglitz, U Novelli-Fischer, et al.
Cancer|May 15, 1994
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patientB G Haffty, L Wilmarth, L Wilson, et al.
Cancer|August 15, 1997
Prognostic factors in idiopathic (primary) osteomyelofibrosisH M Kvasnicka, J Thiele, C Werden, et al.
Cancer|June 1, 1982
High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapyD R Vlock, J M Kirkwood, C Leutzinger, et al.
Cancer|February 26, 1998
Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registriesC G Fischer, W Waechter, S Kraus, et al.
Cancer|July 19, 2011
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancerJill Gilbert, Barbara Murphy, Mary S Dietrich, et al.
Cancer|July 28, 2009
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert Haddad, Stephen Sonis, Marshall Posner, et al.
Cancer|April 5, 2022
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trialNaomi Kiyota, Makoto Tahara, Bruce Robinson, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Cancer|September 15, 1995
Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequenceS E Baldus, M Vierbuchen, F G Hanisch, et al.
Cancer|April 1, 1979
Results of radiotherapy in control of stage I and II non-Hodgkin's lymphomaM G Chen, L R Prosnitz, A Gonzalez-Serva, et al.
Cancer|May 18, 1999
Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapyF C Dimeo, R D Stieglitz, U Novelli-Fischer, et al.
Cancer|May 15, 1994
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patientB G Haffty, L Wilmarth, L Wilson, et al.
Cancer|August 15, 1997
Prognostic factors in idiopathic (primary) osteomyelofibrosisH M Kvasnicka, J Thiele, C Werden, et al.
Cancer|June 1, 1982
High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapyD R Vlock, J M Kirkwood, C Leutzinger, et al.
Cancer|February 26, 1998
Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registriesC G Fischer, W Waechter, S Kraus, et al.
Cancer|July 19, 2011
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancerJill Gilbert, Barbara Murphy, Mary S Dietrich, et al.
Cancer|July 28, 2009
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert Haddad, Stephen Sonis, Marshall Posner, et al.
Cancer|April 5, 2022
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trialNaomi Kiyota, Makoto Tahara, Bruce Robinson, et al.
Pageof 9